Press release
Breast Cancer Therapeutics Market Growth Analysis 2024
The lead author of this research report says, “New product launches and investments in clinical testing and trials are also expected to work in the favor of drug breast cancer therapeutics companies to diversify their portfolio and win bigger shares.”
Increased Breast Cancer Risk to Pave Way for Steady Consumption of Breast Cancer Therapeutics
The increasing risk of breast cancer amongst women due to early onset of menopause, growing pool of geriatric women, and lifestyle changes are some of the factors driving the breast cancer therapeutics market. The changes in delayed childbearing, reproductive patterns, reduced breast feeding, excessive intake of oral contraceptive pills, and other estrogen modifying drug therapies are also contributing to the increasing risks of breast cancer amongst women.
The growing problem of obesity is also considered to be a major factor contributing towards rising cases of breast cancer. The fat tissues are known to be major producers of estrogen amongst postmenopausal women. Thus, excess fat and the high prevalence of obesity is indirectly driving the global breast cancer therapeutics market.
The growth of domestic pharmaceutical companies that are making investments to meet the unmet demands of patients by manufacturing generic drugs as several patented drugs reach their patient expiration date are expected to boost the market. Furthermore, this market is also expected to find opportunity in developing companion diagnostic models that are customized for specific patients in accordance with the molecular characteristics of their malignancy.
Request to download and view full ToC -
http://www.transparencymarketresearch.com/report-toc/5678
Entry of Local Manufacturers Could Eat into Revenues of Branded Drugs
However, the entry of local drug manufacturers has intensified the competition in the breast cancer therapeutics market. These manufacturers are offering generic versions of breast cancer drugs, which is severely impacting the market for branded drugs. The exorbitant cost of surgeries, radiation therapy, and chemotherapy also makes it unaffordable for a large number of patients, especially in the developing regions, where healthcare infrastructure is poor. All of these factors are expected to hamper the growth of the breast cancer therapeutics market in the foreseeable future.
Request to view Sample Report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5678
Patent Expiry Drives HER2 Inhibitors Segment as Generic Drugs will Become Affordable
Currently, North America holds a sizeable share in the global breast cancer therapeutics market due to supportive insurance schemes. In the coming years, this regional segment will acquire a 36.2% share of the overall market revenue. The significant drug segment in the market will be HER2 inhibitors in the forecast period as patents near expiration dates, giving entry to generic drugs. Thus, this drug segment will expand at a CAGR of 6.2% between 2015 and 2023. Given these positive developments, the opportunity in the overall market is also expected to rise to US$16.21 bn by 2023 from US$7.17 bn in 2014, enabling the market to exhibit a CAGR of 8.4% between 2015 and 2023.
Breast Cancer Therapeutics Market Report is available @ US$ 5795
http://www.transparencymarketresearch.com/checkout.php?rep_id=5678<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Therapeutics Market Growth Analysis 2024 here
News-ID: 746760 • Views: …
More Releases from Transparecny Market Research
HAZMAT Packaging Market Share, Trends, Growth, Forecast By 2027
The global HAZMAT Packaging Market is estimated to flourish at a CAGR of 5.8% from 2024 to 2027.
The overall HAZMAT Packaging industry delivers an in-depth systematic framework and competitive outlook of the HAZMAT Packaging Market from a worldwide perspective. The report starts with a summary of the market, chain structure, and the past as well as current market size. Also, the growth opportunities prevalent in the market in the coming…
Push Pull Closures Market Will Generate New Growth Opportunities by 2027 with To …
The global Push Pull Closures Market is estimated to flourish at a CAGR of 4.8% from 2024 to 2027.
The overall Push Pull Closures industry delivers an in-depth systematic framework and competitive outlook of the Push Pull Closures Market from a worldwide perspective. The report starts with a summary of the market, chain structure, and the past as well as current market size. Also, the growth opportunities prevalent in the market…
PET Preform Machines Market Estimated to Touch USD 14.1 billion at a CAGR of 6.0 …
The global PET Preform Machines Market has been sailing through robust waters, witnessing a valuation of US$ 8.3 Bn 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 6.0% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$ 14.1…
Flexible Packaging Paper Market Share, Trends, Growth, Forecast By 2029
The global Flexible Packaging Paper Market has been sailing through robust waters, witnessing a valuation of US$ 47.5 Bn 2021. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 4.1% from 2023 to 2029. By the end of 2029, the industry is expected to anchor at an impressive US$ 65.2…
More Releases for Breast
Breast Ultrasound Market Research Report and Forecast to 2028 - Conventional Bre …
A breast ultrasound is an imaging method chiefly utilized to screen for tumours and other breast abnormalities. The ultrasound use high-frequency sound waves for the production of detailed images of the inside of the breasts.
The global Breast Ultrasound Market is expected to grow at a significant CAGR of 14.6% by 2028.
The updated report on the Breast Ultrasound market gives a precise analysis of the value chain assessment for the review…
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Download Free PDF Brochure on Brest Imaging Market Report Now…
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to…
Automated Breast Ultrasound Systems – The Future of Breast Screening
Breast cancer is the most commonly diagnosed type of cancer and the second leading cause of death among women, as evident from stats revealed by the National Breast Cancer Foundation. Growing awareness of breast cancer has increased number of women undergoing breast screening and in turn would propel demand for automated breast ultrasound systems (ABUS) in hospitals and diagnostic centers. ABUS enables physicians to screen women, especially with denser breasts…
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging…
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed?
Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can…
